Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00176865
What this trial is testing

Stem Cell Transplant for Immunologic or Histiocytic Disorders

Who this might be right for
Hemophagocytic LymphohistiocytosisX-Linked Lymphoproliferative DisordersChediak-Higashi Syndrome+3 more
Masonic Cancer Center, University of Minnesota 19
Early research (Phase 1)Study completedNCT01169038
What this trial is testing

Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis

Who this might be right for
Pulmonary SarcoidosisLung Function
Vanderbilt University 15
Not applicableStudy completedNCT06049004
What this trial is testing

Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis Patients

Who this might be right for
Idiopathic Pulmonary FibrosisActivity, Motor
Izmir Katip Celebi University 30
Not applicableLooking for participantsNCT07486206
What this trial is testing

Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

Who this might be right for
Interstitial Lung Disease (ILD)Fibrotic Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis (IPF)+2 more
Hospital de Granollers 152
Large-scale testing (Phase 3)Looking for participantsNCT07284602
What this trial is testing

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
PureTech 1,100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07674745
What this trial is testing

Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Alabama at Birmingham 52
Large-scale testing (Phase 3)UnknownNCT04497831
What this trial is testing

Morphine for Dyspnea in Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Medical University of Gdansk 20
Not applicableApproved For MarketingNCT02171156
What this trial is testing

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT01906931
What this trial is testing

Ambulatory Oxygen for ILD

Who this might be right for
Interstitial Lung Disease
Anne Holland 10
Not applicableLooking for participantsNCT07320846
What this trial is testing

The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis

Who this might be right for
ExercisePulmonary RehabilitationInterstitial Lung Disease+3 more
Saglik Bilimleri Universitesi 39
Testing effectiveness (Phase 2)UnknownNCT02809456
What this trial is testing

Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients

Who this might be right for
Radiation Pneumonitis
Taipei Medical University WanFang Hospital 50
Not applicableStudy completedNCT05870956
What this trial is testing

Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 1,798
Post-approval studies (Phase 4)Looking for participantsNCT06611696
What this trial is testing

Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis

Who this might be right for
ANCA Associated Vasculitis (AAV)
Chiba University 160
Testing effectiveness (Phase 2)Study completedNCT04855305
What this trial is testing

Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease

Who this might be right for
Interstitial Lung Diseases
Bastiaan Driehuys 47
Not applicableStudy completedNCT05716334
What this trial is testing

Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

Who this might be right for
ANCA-associated VasculitisGranulomatosis With PolyangiitisMicroscopic Polyangiitis
McGill University Health Centre/Research Institute of the McGill University Health Centre 201
Early research (Phase 1)Looking for participantsNCT04362644
What this trial is testing

Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Alabama at Birmingham 10
Testing effectiveness (Phase 2)Study completedNCT00001256
What this trial is testing

Steroids and Methotrexate to Treat Systemic Vasculitis

Who this might be right for
InflammationVasculitisWegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableUnknownNCT03666234
What this trial is testing

Idiopathic Pulmonary Fibrosis Registry China Study

Who this might be right for
Idiopathic Pulmonary Fibrosis
Dai Huaping 800
Not applicableUnknownNCT01154998
What this trial is testing

Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Pneumonia
St George's Healthcare NHS Trust 360
Early research (Phase 1)UnknownNCT04537130
What this trial is testing

Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge

Who this might be right for
Pulmonary FibrosisCovid19
Instituto Oncológico Dr Rosell 40
Next Page